# Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension

Study · id `cardio:ct-nct03354897` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03354897](<https://clinicaltrials.gov/study/NCT03354897>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03354897

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 228 participants.

## Technical summary

Registry record NCT03354897. Allocation not applicable; no masking; primary purpose treatment. Start 2017-04-05 (actual); primary completion 2021-10-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 228 participants (enrolled count; ClinicalTrials.gov record NCT03354897, source copy `cardio:ctgov-nct03354897-2023-09-25`, retrieved 2026-10-26)
- Started: 2017-04-05 (actual) (ClinicalTrials.gov record NCT03354897, source copy `cardio:ctgov-nct03354897-2023-09-25`, retrieved 2026-10-26)
- Primary completion: 2021-10-30 (actual) (ClinicalTrials.gov record NCT03354897, source copy `cardio:ctgov-nct03354897-2023-09-25`, retrieved 2026-10-26)
- Completion: 2021-10-30 (actual) (ClinicalTrials.gov record NCT03354897, source copy `cardio:ctgov-nct03354897-2023-09-25`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT03354897, source copy `cardio:ctgov-nct03354897-2023-09-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03354897-2023-09-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension
- Acronym: UMOD
- Condition: Cardiovascular Diseases
- Condition: Hypertension
- Intervention (Drug): Torasemide 5Mg Tablet
- Lead sponsor: NHS Greater Glasgow and Clyde
- Lead sponsor class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER
- Collaborator: British Heart Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: NHS Greater Glasgow and Clyde (`cardio:org-nhs-greater-glasgow-and-clyde`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)
- Registry lists this organization as a collaborator: British Heart Foundation (`cardio:org-british-heart-foundation`)

## Provenance

Content hash: f42c1cb1fbab4825189394cdf85773d0c872f09cbfc0f3c2999de72f511ca04a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
